Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Hypofractionated Radiotherapy in Glioblastoma
NCT01120639Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2010
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in glioblastoma multiforme (GBM), sponsored by Stanford University. Started Apr 2010; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01120639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120639.